Related Experiment Video
Updated: Oct 15, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Reduced expression of miR-30c-5p promotes hepatocellular carcinoma progression by targeting RAB32
Zheng He1, Meng Tian1, Xuan Fu1
1Department of General Surgery, Shiyan People's Hospital of Bao'an District, No. 11 Jixiang Road, Bao'an District, Shenzhen, 518108 Guangdong, China.
Abstract:
Hepatocellular carcinoma (HCC) remains among the most lethal of human cancers, despite recent advances in modern medicine. miR-30c-5p is frequently dysregulated in different diseases. However, the effects and the underlying mechanism of miR-30c-5p in HCC are still elusive. Here, we show that miR-30c-5p is downregulated in HCC and significantly associated with survival and tumor size in patients with HCC. We demonstrate that aberrant miR-30c-5p markedly affects HCC cell proliferation and migration. Further experiments show that RAB32 is an essential target of miR-30c-5p in HCC. These studies highlight an important role of miR-30c-5p in growth and invasion of HCC and indicate that the miR-30c-5p-RAB32 axis is an important underlying mechanism.
Insights
MicroRNA-30c-5p (miR-30c-5p) is downregulated in hepatocellular carcinoma (HCC), impacting patient survival and tumor growth. This study reveals the miR-30c-5p-RAB32 pathway as a key mechanism in HCC progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death globally.
- MicroRNAs (miRNAs) are small non-coding RNAs involved in gene regulation and disease pathogenesis.
- The specific role and mechanism of miR-30c-5p in HCC remain largely unknown.
Purpose of the Study:
- To investigate the expression, function, and mechanism of miR-30c-5p in hepatocellular carcinoma.
- To determine the clinical significance of miR-30c-5p in HCC patients.
- To identify the molecular targets of miR-30c-5p in HCC.
Main Methods:
- Quantitative real-time PCR to assess miR-30c-5p expression levels in HCC tissues and cell lines.
- Cell proliferation and migration assays to evaluate the functional impact of miR-30c-5p.
- Bioinformatic analysis and luciferase reporter assays to identify and validate miR-30c-5p targets.
Main Results:
- miR-30c-5p was significantly downregulated in HCC tissues compared to non-tumor tissues.
- Lower miR-30c-5p expression correlated with poorer patient survival and larger tumor size.
- Restoration of miR-30c-5p suppressed HCC cell proliferation and migration.
- RAB32 was identified as a direct and functional target of miR-30c-5p in HCC.
Conclusions:
- miR-30c-5p acts as a tumor suppressor in hepatocellular carcinoma.
- The downregulation of miR-30c-5p contributes to HCC progression by upregulating RAB32.
- The miR-30c-5p-RAB32 axis represents a potential therapeutic target for HCC.
More Related Videos
Related Concept Videos
MicroRNAs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

